The British-Swedish pharmaceutical AstraZeneca announced that the COVID-19 vaccine, in conjunction with the British University of Oxford, has been renamed Vaxzevria.
As reported in The Brussels Times, the name change was approved on March 25 following a request from the company and was announced on the website of the European Medicines Agency (EMA) and that of the Swedish National Medicines Agency (Läkemedelsverket).
